Device Trial Radar · NCT01810679
Perceval S Aortic Heart Valve Study- North America
Last checked: Nov 20, 2026Latest source record: Nov 16, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Sorin Group USA, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 13, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate the safety and effectiveness of the Perceval S heart valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
Conditions
- Aortic Valve Stenosis
- Aortic Valve Stenosis With Insufficiency
- Regurgitation, Aortic Valve
- Aortic Valve Incompetence
Interventions
Perceval S Aortic Heart ValveDevice
Perceval S Sutureless Aortic Heart Valve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety EndpointTime frame: One-year
1 more outcomes with a free account
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
East Alabama Medical Center
Opelika, Alabama
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.